Market momentum Faks has recently secured a significant €6M funding round led by Speedinvest with participation from notable investors, signaling strong growth runway and validation from respected VC players. This momentum presents an opportunity to approach potential customers with confidence in product viability and long-term support.

Pharmacy scale With 18,000 partner pharmacies and a dedicated team focused on pharmacy operations, Faks offers a proven platform for centralizing supplier management. This scale suggests high adoption potential in large pharmacy networks seeking efficiency gains and revenue optimization.

Laboratory value Faks claims substantial efficiency lift for labs (20% to 60% of sell-out time) and secure revenue growth without extra field effort. Targeting pharma laboratories and distributors with high repetitive ordering could drive compelling ROI messaging and case study opportunities.

Integrated ecosystem Konnect enables seamless integrations with accounting software, professional spaces, LGO, and PLV tools, reducing operational friction. Sales plays could emphasize quick wins through existing tech stacks and highlight smooth onboarding for multi-tool environments.

Network leverage With 700 laboratories and 130 groupements, plus partner networks across pharmacies, there is an opportunity to promote bundled value propositions to groups and cooperatives, offering standardized supplier governance, margin improvements, and coordinated supplier relations.